Motor cortex and corticospinal excitability in humans with a history of illicit stimulant use

Journal of Applied Physiology

Volumn 113, Issue 9, 2012, Pages 1486-1494

  Flavel, Stanley C ^a   White, Jason M ^a   Todd, Gabrielle ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Illicit stimulants; Motor cortex; Transcranial magnetic stimulation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CENTRAL STIMULANT AGENT; METHAMPHETAMINE;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; DRUG ABUSE; ELECTROMYOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HUMAN; MALE; MIDDLE AGED; MOTOR CORTEX; PATHOPHYSIOLOGY; PYRAMIDAL TRACT; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; ELECTROMYOGRAPHY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; METHAMPHETAMINE; MIDDLE AGED; MOTOR CORTEX; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PYRAMIDAL TRACTS; SUBSTANCE-RELATED DISORDERS; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 84868324460     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00718.2012     Document Type: Article

References (61)

1. AIHW. 2010 National Drug Strategy Household Survey Report. Canberra, Australia: Australian Institute of Health and Welfare, 2011.
2. AIHW. Statistics on Drug Use in Australia 2004. Canberra, Australia: Australian Institute of Health and Welfare, 2005.
3. Amassian VE, Quirk GJ, Stewart M. A comparison of corticospinal activation by magnetic coil and electrical stimulation of monkey motor cortex. Electroencephalogr Clin Neurophysiol 77: 390-401, 1990.
4. Baker SN, Olivier E, Lemon RN. Task-related variation in corticospinal output evoked by transcranial magnetic stimulation in the macaque monkey. J Physiol 488: 795-801, 1995.
5. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corp., 1996.
6. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol 72: 3-12, 1993.
7. Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City: AJA Associates, 1983.
8. Boutros NN, Lisanby SH, McClain-Furmanski D, Oliwa G, Gooding D, Kosten TR. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. J Psychiatr Res 39: 295-302, 2005.
9. Boutros NN, Lisanby SH, Tokuno H, Torello MW, Campbell D, Berman R, Malison R, Krystal JH, Kosten T. Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. Biol Psychiatry 49: 369-373, 2001.
10. Burke D, Hicks R, Gandevia SC, Stephen J, Woodforth I, Crawford M. Direct comparison of corticospinal volleys in human subjects to transcranial magnetic and electrical stimulation. J Physiol 470: 383-393. 1993.
11. Callaghan RC, Cunningham JK, Sajeev G, Kish SJ. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Mov Disord 25: 2333-2339, 2010.
12. Cardoso F, Jankovic J. Movement disorders. Neurol Clin 11: 625-638, 1993.
13. Cardoso FE, Jankovic J. Cocaine-related movement disorders. Mov Disord 8: 175-178, 1993.
14. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Meglio M, Cioni B, Colosimo C, Tonali PA, Rothwell JC. Direct recording of the output of the motor cortex produced by transcranial magnetic stimulation in a patient with cerebral cortex atrophy. Clin Neurophysiol 115: 112-115, 2004.
15. Downes MA, Whyte IM. Amphetamine-induced movement disorder. Emerg Med Australas 17: 277-280, 2005.
16. Edgley SA, Eyre JA, Lemon RN, Miller S. Excitation of the corticospinal tract by electromagnetic and electrical stimulation of the scalp in the macaque monkey. J Physiol 425: 301-320, 1990.
17. Farrell PE, Diehl AK. Acute dystonic reaction to crack cocaine. Ann Emerg Med 20: 322, 1991.
18. Fitzgerald PB, Williams S, Daskalakis ZJ. A transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability. Neuropsychopharmacology 34: 2368-2375, 2009.
19. Gjini K, Ziemann U, Napier TC, Boutros N. Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patients. J Psychiatr Res 46: 248-255, 2012.
20. Greco PG, Garris PA. In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry. Eur J Pharmacol 479: 117-125, 2003.
21. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55: 463-508, 2003.
22. Grigsby J, Kaye K. Alphanumeric sequencing and cognitive impairment among elderly persons. Percept Mot Skills 80: 732-734, 1995.
23. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18: 1979-1986, 1998.
24. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165: 917-928, 2001.
25. Kear-Colwell JJ, Heller M. A normative study of the Wechsler Memory Scale. J Clin Psychol 34: 437-442, 1978.
26. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferber A, Wroe S, Asselman P, Marsden CD. Corticocortical inhibition in human motor cortex. J Physiol 471: 501-519, 1993.
27. Loo CK, Sachdev P, Mitchell PB, Gandevia SC, Malhi GS, Todd G, Taylor JL. A study using transcranial magnetic stimulation to investigate motor mechanisms in psychomotor retardation in depression. Int J Neuropsychopharmacol 1-12, 2008.
28. Lundh H, Tunving K. An extrapyramidal choreiform syndrome caused by amphetamine addiction. J Neurol Neurosurg Psychiatry 44: 728-730, 1981.
29. Maeda F, Keenan JP, Pascual-Leone A. Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation. Br J Psychiatry 177: 169-173, 2000.
30. Mantle TJ, Tipton KF, Garrett NJ. Inhibition of monoamine oxidase by amphetamine and related compounds. Biochem Pharmacol 25: 2073-2077, 1976.
31. McCann UD, Ridenour A, Shaham Y, Ricaurte GA. Serotonin neurotoxicity after (+/-) 3, 4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology 10: 129-138, 1994.
32. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 352: 1433-1437, 1998.
33. Merab J. Acute dystonic reaction to cocaine. Am J Med 84: 564, 1988.
34. Mittenberg W, Burton DB, Darrow E, Thompson GB. Normative data for the Wechsler Memory Scale-Revised: 25-to 34-year-olds. Psychol Assess 4: 363-368, 1992.
35. Mrazik M, Millis S, Drane DL. The oral trail making test: effects of age and concurrent validity. Arch Clin Neuropsychol 25: 236-243, 2010.
36. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113, 1971.
37. Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 17: 309-312, 2002.
38. Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ. MDMA ("ecstasy") and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol 21: 1001-1007, 2000.
39. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 37: 181-188, 1995.
40. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 120: 2008-2039, 2009.
41. Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict Behav 29: 743-752, 2004.
42. Scorza MC, Carrau C, Silveira R, Zapata-Torres G, Cassels BK, Reyes-Parada M. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships. Biochem Pharmacol 54: 1361-1369, 1997.
43. Segal DL, Coolidge FL, Cahill BS, O'Riley AA. Psychometric properties of the Beck Depression Inventory II (BDI-II) among community-dwelling older adults. Behav Modif 32: 3-20, 2008.
44. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15: 4102-4108, 1995.
45. Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75: 406-433, 2005.
46. Sundaresan K, Ziemann U, Stanley J, Boutros N. Cortical inhibition and excitation in abstinent cocaine-dependent patients: a transcranial magnetic stimulation study. Neuroreport 18: 289-292, 2007.
47. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 14: 167-177, 1999.
48. Toomey R, Lyons MJ, Eisen SA, Xian H, Chantarujikapong S, Seidman LJ, Faraone SV, Tsuang MT. A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry 60: 303-310, 2003.
49. NODC. Amphetamines and Ecstasy: 2011 Global ATS Assessment. Viena, Austria: United Nations Office on Drugs and Crime, 2011.
50. UNODC. World Drug Report. New York: United Nations Office on Drugs and Crime, 2009.
51. Vickers D, Nettelbeck T, Willson RJ. Perceptual indices of performance: the measurement of "inspection time" and "noise" in the visual system. Perception 1: 263-295, 1972.
52. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021, 2001.
53. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21: 9414-9418, 2001.
54. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377-382, 2001.
55. Wechsler D. Wechsler Adult Intelligence Scale (revised). New York: Psychological Corp., 1981.
56. Wechsler D. Wechsler Memory Scale (revised). New York: Psychological Corp., 1987.
57. Yamamoto BK, Bankson MG. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit Rev Neurobiol 17: 87-117, 2005.
58. Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities: classical and emerging mechanisms. Ann NY Acad Sci 1187: 101-121, 2010.
59. Ziemann U. TMS and drugs. Clin Neurophysiol 115: 1717-1729, 2004.
60. Ziemann U, Bruns D, Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 208: 187-190, 1996.
61. Ziemann U, Rothwell JC. I-waves in motor cortex. J Clin Neurophysiol 17: 397-405, 2000.